References
- Chiang JL, Maahs DM, Garvvey KC, et al. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018;41(9):2026–2044. doi:10.2337/dci18-0023
- Gregory GA, Robinson TIG, Linklater SE, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741–760. doi:10.1016/S2213-8587(22)00218-2
- Mottl AK, Tuttle KR, Bakris GL Diabetic Kidney Dis. Waltham MA: UpToDate Inc. Available from: http://www.uptodate.com. Accessed January 28, 2023.
- Ogle GD, James S, Dabelea D, et al. Global estimates of incidence of type 1 diabetes in children and adolescents: results from the international diabetes federation atlas, 10th edition. Diabetes Res Clin Pract. 2022;183:109083. doi:10.1016/j.diabres.2021.109083
- Costacou T, Orchard TJ. Cumulative kidney complication risk by 50 years of type 1 diabetes: the effects of sex, age, and calendar year at onset. Diabetes Care. 2018;41(3):426–433. doi:10.2337/dc17-1118
- Orchard TJ. Cardiovascular disease in type 1 diabetes: a continuing challenge. Lancet Diabetes Endocrinol. 2021;9(9):548–549. doi:10.1016/S2213-8587(21)00190-X
- Perkins BA, Bebu I, de Boer IH, et al. Risk factors for kidney disease in type-1 diabetes. Diabetes Care. 2019;42(5):883–890. doi:10.2337/dc18-2062
- Roy S, Kahn OS, Jafry B, et al. Risk factors and comorbidities associated with diabetic kidney disease. J Prim Care Community Health. 2021;12:1–10. doi:10.1177/21501327211048556
- Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world-wide difference of prevalence and risk factors. J Nephropharmacol. 2016;5(1):49.
- Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;1(S1):3–15. doi:10.1111/dom.14007
- Naser AY, Alwafi H, Alotaibi B, et al. Prevalence of chronic kidney diseases in patients with diabetes mellitus in the middle east: a systematic review and meta-analysis. Int J Endocrinol. 2021;2021:4572743. doi:10.1155/2021/4572743
- Abdel-Motal UM, Akila G, Abdelalim EM, et al. Prevalence of nephropathy in type-1 diabetes in the Arab world: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2018;34(7):e3026. doi:10.1002/dmrr.3026
- Hoogveen EK. The epidemiology of diabetic kidney disease. Kidney Dial. 2022;2(3):433. doi:10.3390/kidneydial2030038
- Al-Rubeaan K, Siddiqui K, Alghonaim M, Youssef AM, AlNaqeb D. The Saudi Diabetic Kidney disease (Saudi DKD): clinical characteristics and biochemical parameters. Ann Saudi Med. 2018;38(1):46. doi:10.5144/0256-4947.2018.03.01.1010
- Siddiqui K, Joy SS. Risk factors and management of kidney diseases in Saudi women with diabetes. Curr Womens Health Rev. 2020;16(2):95–101. doi:10.2174/1573404816666200206110002
- Ahmed HG, Alzayed FSM, Albluwe HKA, et al. Etiology of chronic kidney disease (CKD) in Saudi Arabia. Int J Med Res Health. 2019;8(5):177–182.
- Top 10 causes of death by rate in 2015. Institute for Health Metrics and Evaluation. Saudi Arabia; 2018. Available from: https://www.healthdata.org/saudi-arabia. Accessed October 30, 2023.
- Press Report on the MOH’s Efforts Regarding Raising People’s Awareness of Diabetes. MOH Publication; 2013. Available from: https://www.moh.gov.sa/en/Ministry/MediaCenter/Publications/Pages/Publications-2013-06-09-004.aspx. Accessed October 30, 2023.
- Sultana S, Alquraishi R, Alqarni T, Alnefaie M, Kalakattawi A, Alzahrani R. Risk factors and knowledge assessment of general public for chronic kidney disease in Taif Region, Saudi Arabia. World J Adv Res Rev. 2020;8(1):123–143. doi:10.30574/wjarr.2020.8.1.0373
- Kajoak S, Bushra W, Elnour H, et al. Study of renal disease during computed tomography in Taif, Saudi Arabia. Med Sci. 2023;27(132):1–9. doi:10.54905/disssi/v27i132/e94ms2823
- Robert AA, Al-Dawish A, Mujammami M, Al Dawish MA. Type 1 diabetes mellitus in Saudi Arabia: a soaring epidemic. Int J Ped. 2018;9408370. doi:10.1155/2018/9408370
- Al-Agha AE, Alafif M, Abd-Elhameed IA. Glycemic control, complications and associated diseases in Jeddah Saudi Arabia. Saudi Med J. 2015;36(1):26–31. doi:10.15537/smj.2015.1.9829
- de Boer IH, Khunti K, Sadusky T, et al. Diabetic management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and kidney disease: improving global outcomes (KIDGO). Diabetes Care. 2022;45(12):3075–3090. doi:10.2337/dci22-0027
- Nazzal Z, Hamdan Z, Masri D, Abu-Kaf O, Hamad M. Prevalence and risk factors of chronic kidney disease among Palestinian type 2 diabetic patients: a cross-sectional study. BMC Nephrol. 2020;21(1):1–8. doi:10.1186/s12882-020-02138-4
- Cirillo M, Lombardi C, Chiricone D, Bilancio G, Marcarelli F, De Santo NG. Early identification of kidney disease by eGFR: what is the prevalence of eGFR in the population? J Nephrol. 2008;21:S102–6.
- James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. 2014;311(5):507–520. doi:10.1001/jama.2013.284427
- Bamashmoos MA, Ganem Y. Diabetic nephropathy and its risk factors in type 2-diabetic patients in Sana’a City, Yemen. World J Med Sci. 2013;9(3):147–152.
- Majeed MS, Ahmed F, Teeling M. The prevalence of chronic kidney disease and albuminuria in patients with type-1 and type-2 diabetes attending a single centre. Cureus. 2022;14(12):e32248. doi:10.7759/cureus.32248
- Alghaythi AM, Alsudayri MST, Alshammari F, et al. Prevalence of diabetes among patients with chronic kidney disease in Hail Region. Egypt J Hospital Med. 2018;71(2):2434–2442. doi:10.12816/0045638
- Giandalia A, Giuffrida AE, Gembillo G, et al. Gender differences in diabetic kidney disease: focus on hormonal, genetic and clinical factors. Int J Mol Sci. 2021;22(11):5808. doi:10.3390/ijms22115808
- Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151–164. doi:10.1038/nrneph.2017.181
- Damtie S, Biadgo B, Baynes HW, et al. chronic kidney disease and associated risk factors assessment among diabetes mellitus patients at a tertiary hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018;28(6):691–700. doi:10.4314/ejhs.v28i6.3
- Ahmed H, Elshaikh T, Abdullah M, Wallner M. Early diabetic nephropathy and retinopathy in patients with type 1 diabetes mellitus attending Sudan childhood diabetes centre. J Diabetes Res. 2020;2020:718138. doi:10.1155/2020/7181383
- Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population- based cohort study. BMJ. 2019;366:l4894. doi:10.1136/bmj.l4894
- Ku E, McCulloch CE, Mauer M, Gitelman SE, Grimes BA, Hsu CY. Association between blood pressure and adverse renal events in type-1 diabetes. Diabetes Care. 2016;39(12):2218–2224. doi:10.2337/dc16-0857